Quick Takeaways
- SB INVESTMENT ADVISERS (UK) LTD filed SCHEDULE 13G/A for Vir Biotechnology, Inc. Common Stock, $0.0001 par value (VIR).
- Disclosed ownership: 9.4%.
- Date of event: 31 Dec 2025.
SB INVESTMENT ADVISERS (UK) LTD - 31 Dec 2025 SCHEDULE 13G/A Report for Vir Biotechnology, Inc. Common Stock, $0.0001 par value (VIR)
- Filing Manager
- SB INVESTMENT ADVISERS (UK) LTD
- Reporting Manager
- SB Investment Advisers (UK) Limited
- Symbol
- VIR
- Shares outstanding
- 139,542,309 shares
- Disclosed Ownership
- 13,116,977 shares
- Ownership
- 9.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 17:00:08 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"SB INVESTMENT ADVISERS (UK) LTD disclosed 9.4% ownership in Vir Biotechnology, Inc. Common Stock, $0.0001 par value (VIR) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 17:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| SB Investment Advisers (UK) Limited | 9.4% | 13,116,977 | 0 | 13,116,977 | /s/ Amanda Sanchez-Barry | Amanda Sanchez-Barry, General Counsel | |
| SoftBank Vision Fund (AIV M1) L.P. | 9.4% | 13,116,977 | 0 | 13,116,977 | By: SB Investment Advisers (UK) Limited, its Manager, /s/ Amanda Sanchez-Barry | Amanda Sanchez-Barry, General Counsel | |
| SVF Endurance (Cayman) Limited | 9.4% | 13,116,977 | 0 | 13,116,977 | /s/ Nilani Perera | Nilani Perera, Director |